financetom
Business
financetom
/
Business
/
BRIEF-Pepsico Is In Advanced Talks To Acquire Tortilla-Chip Maker Siete Foods For More Than $1 Bln - WSJ
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Pepsico Is In Advanced Talks To Acquire Tortilla-Chip Maker Siete Foods For More Than $1 Bln - WSJ
Oct 2, 2024 9:49 PM

Sept 30 (Reuters) -

* PEPSICO IS IN ADVANCED TALKS TO ACQUIRE TORTILLA-CHIP

MAKER

SIETE FOODS FOR MORE THAN $1 BILLION - WSJ

Source text : https://tinyurl.com/27xqryov

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Why InMed's Alzheimer's Drug Candidate Is Fueling Sudden Stock Surge
Why InMed's Alzheimer's Drug Candidate Is Fueling Sudden Stock Surge
Jun 24, 2025
InMed Pharmaceuticals Inc. ( INM ) stock is surging early Tuesday, with a session volume of 6.63 million compared to the average volume of 1.31 million, as per data from Benzinga Pro. On Tuesday, InMed released new preclinical data demonstrating that INM-901 significantly reduces inflammation in ex vivo models of neuroinflammation, further supporting its potential as a therapeutic candidate for...
TuHURA Biosciences Launches Phase 3 Study of Potential Cancer Immunotherapy Drug
TuHURA Biosciences Launches Phase 3 Study of Potential Cancer Immunotherapy Drug
Jun 24, 2025
09:00 AM EDT, 06/24/2025 (MT Newswires) -- TuHURA Biosciences ( HURA ) said Tuesday it has launched a phase 3 study of IFx-2.0 as an adjunctive therapy to Keytruda in the first-line treatment of advanced or metastatic Merkel cell carcinoma. The study will assess overall response rate as the primary endpoint and progression-free survival as a key secondary endpoint, the...
Ondas, Mistral Form Partnership to Market Drone Systems to US Defense Sector
Ondas, Mistral Form Partnership to Market Drone Systems to US Defense Sector
Jun 24, 2025
09:00 AM EDT, 06/24/2025 (MT Newswires) -- Ondas Holdings ( ONDS ) said Tuesday its American Robotics unit formed a partnership with Mistral to market autonomous drone platforms to US defense and homeland security sectors. American Robotics will work with Mistral on joint marketing and sales of the Optimus drone system and Iron Drone Raider intercepting system. The agreement has...
Copyright 2023-2026 - www.financetom.com All Rights Reserved